/
/
/

Bafna Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)301.60
Volume (₹)4,475.00
High (₹)303.10
Upper Circuit313.90
Low (₹)301.60
Lower Circuit301.60
Prev Close307.75
52W High (₹)318.50
Price301.60
52W Low (₹)94.77

Share Market Cap & Key Ratios Overview

M.Cap (₹)729.92 Cr
Div. Yield (%)0.00
PE Ratio93.72
Debt to Equity0.39
Price to Book2.78
Book Value40.64
EPS (TTM)3.29
Face Value10.00
ROE (%)12.27

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
AUROPHARMANSE
LUPINNSE
DRREDDYNSE
MANKINDNSE
BAFNAPH-BENSE
LTP
1W Low
1W High
Market cap (₹)
1864.9-34.1 (-1.80%)
1864.90
1907.80
4,51,339Cr
9488+388 (4.26%)
9119.50
9615
2,54,068Cr
4930+73 (1.50%)
4823
4992
1,88,767Cr
1127.4+7.4 (0.66%)
1114.10
1167.70
1,14,713Cr
1363.1-21.9 (-1.58%)
1363.10
1398.40
1,11,804Cr
1937+97 (5.27%)
1832.70
1955
1,05,118Cr
1698.9+45.8 (2.77%)
1646
1704
97,009Cr
2100-10 (-0.47%)
2090
2135.50
96,575Cr
1145-6 (-0.52%)
1136.40
1163.20
96,113Cr
2265-62.9 (-2.70%)
2250
2331.60
95,242Cr
301.6+5.75 (1.94%)
301
307.75
730Cr

Key Highlights of Bafna Pharmaceuticals Ltd Balance Sheet

Bafna Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹23.66Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹23.66Cr, and the reserves and surplus of the company is ₹72.49Cr.

The company has its non-current liabilities with total liabilities of ₹175.53Cr as of 2026-03-31.

The current liabilities are ₹57.19Cr as of 2026-03-31. At the same time, current assets are ₹89.65Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of 5000 and tangible assets of ₹81.79Cr, provided in the Bafna Pharmaceuticals Ltd financial statements.